Trial Profile
Efficacy and effects of azelnidipine, olmesartan medoxomil and candesartan cilexetil on the cardiovascular system in outpatients with hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2011
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Candesartan cilexetil (Primary) ; Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 07 Feb 2011 New trial record